Healthcare provider profile · identity verified

Joshua Alphonse Imperio, MD

Internal Medicine · RANCHO MIRAGE, CA · NPI 1447273115

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	569	231
Amlodipine Besylate	Amlodipine Besylate	335	129
Lisinopril	Lisinopril	283	104
Levothyroxine Sodium	Levothyroxine Sodium	267	93
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	251	48
Losartan Potassium	Losartan Potassium	243	96
Metformin Hcl	Metformin Hcl	206	74
Albuterol Sulfate Hfa	Albuterol Sulfate	204	88
Rosuvastatin Calcium	Rosuvastatin Calcium	204	80
Simvastatin	Simvastatin	184	66
Omeprazole	Omeprazole	176	71
Atenolol	Atenolol	175	66
Metformin Hcl Er	Metformin Hcl	157	55
Glipizide	Glipizide	146	53
Tamsulosin Hcl	Tamsulosin Hcl	135	52
Meloxicam	Meloxicam	133	61
Pradaxa	Dabigatran Etexilate Mesylate	123	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	118	27
Gabapentin	Gabapentin	117	47
Metoprolol Tartrate	Metoprolol Tartrate	116	41
Potassium Chloride	Potassium Chloride	116	54
Pantoprazole Sodium	Pantoprazole Sodium	114	40
Ibuprofen	Ibuprofen	112	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	45
Terazosin Hcl	Terazosin Hcl	93	37
Triamcinolone Acetonide	Triamcinolone Acetonide	81	42
Furosemide	Furosemide	80	38
Alendronate Sodium	Alendronate Sodium	76	31
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	76	27
Hydrochlorothiazide	Hydrochlorothiazide	74	32
Trazodone Hcl	Trazodone Hcl	72	35
Tramadol Hcl	Tramadol Hcl	70	24
Finasteride	Finasteride	66	23
Fenofibrate	Fenofibrate	63	23
Allopurinol	Allopurinol	53	20
Prednisone	Prednisone	52	42
Sertraline Hcl	Sertraline Hcl	50	19
Bisoprolol Fumarate	Bisoprolol Fumarate	49	19
Wixela Inhub	Fluticasone Propion/Salmeterol	49	19
Escitalopram Oxalate	Escitalopram Oxalate	48	18
Methocarbamol	Methocarbamol	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	12
Ondansetron Odt	Ondansetron	45	17
Azelastine Hcl	Azelastine Hcl	44	18
Clopidogrel	Clopidogrel Bisulfate	40	18
Lorazepam	Lorazepam	40	12
Spironolactone	Spironolactone	39	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	15
Duloxetine Hcl	Duloxetine Hcl	36	14
Eliquis	Apixaban	36	11
Ezetimibe	Ezetimibe	36	15
Alprazolam	Alprazolam	35	13
Carvedilol	Carvedilol	35	12
Jardiance	Empagliflozin	35	11
Montelukast Sodium	Montelukast Sodium	34	15
Valacyclovir	Valacyclovir Hcl	34	13
Humulin N	Insulin Nph Human Isophane	33	15
Famotidine	Famotidine	32	13
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	32	14
Lovastatin	Lovastatin	30	12
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	12
Sumatriptan Succinate	Sumatriptan Succinate	30	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	29	29
Clonidine Hcl	Clonidine Hcl	29	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	29	17
Azithromycin	Azithromycin	28	27
Cephalexin	Cephalexin	28	23
Liraglutide	Liraglutide	28	suppressed
Victoza 2-Pak	Liraglutide	28	suppressed
Lactulose	Lactulose	27	16
Spiriva Respimat	Tiotropium Bromide	27	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	27	14
Alvesco	Ciclesonide	26	13
Ketoconazole	Ketoconazole	26	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	11
Donepezil Hcl	Donepezil Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	14
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Hydrocortisone	Hydrocortisone	22	15
Metoprolol Succinate	Metoprolol Succinate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Fentanyl	Fentanyl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Trospium Chloride	Trospium Chloride	19	suppressed
Digoxin	Digoxin	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ozempic	Semaglutide	18	suppressed
Baclofen	Baclofen	17	12
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Naproxen	Naproxen	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Cefadroxil	Cefadroxil	15	13
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Cartia Xt	Diltiazem Hcl	14	11
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	14
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amoxicillin	Amoxicillin	12	11
Estradiol	Estradiol	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Sulindac	Sulindac	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error